State Street Corporation 13D and 13G filings for Eagle Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-22 2:04 pm Sale | 2023-12-31 | 13G | Eagle Pharmaceuticals, Inc. EGRX | STATE STREET CORP STT | 222,594 1.710% | -729,432 (-76.62%) | Filing |
| 2023-02-03 4:08 pm Purchase | 2022-12-31 | 13G | Eagle Pharmaceuticals, Inc. EGRX | STATE STREET CORP STT | 952,026 7.310% | 243,802 (+34.42%) | Filing |
| 2022-02-11 09:41 am Sale | 2021-12-31 | 13G | Eagle Pharmaceuticals, Inc. EGRX | STATE STREET CORP STT | 708,224 5.480% | -105,877 (-13.01%) | Filing |
| 2021-02-08 1:14 pm Purchase | 2020-12-31 | 13G | Eagle Pharmaceuticals, Inc. EGRX | STATE STREET CORP STT | 814,101 6.250% | 203,510 (+33.33%) | Filing |
| 2020-02-14 09:38 am Sale | 2019-12-31 | 13G | Eagle Pharmaceuticals, Inc. EGRX | STATE STREET CORP STT | 610,591 4.470% | -216,144 (-26.14%) | Filing |